相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway
Jiangbo Jin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
Subin Jin et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition
Takanori Ohata et al.
CANCER MEDICINE (2017)
20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells
Hui-Han Ai et al.
APOPTOSIS (2017)
MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models
Kaifeng Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
Zhiyuan Tang et al.
ONCOTARGET (2016)
The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients
Hayato Urushima et al.
AGING MALE (2015)
Mechanistic and functional implications of FABP4 in ovarian cancer metastasis
Kshipra M. Gharpure et al.
CANCER RESEARCH (2015)
Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer
Dongbin Bi et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2015)
Kruppel-like factors in hepatocellular carcinoma
Xiao-Jie Lu et al.
TUMOR BIOLOGY (2015)
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Distinction immune genes of hepatitis-induced heptatocellular carcinoma
Jinyu Hu et al.
BIOINFORMATICS (2012)
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies
Jens U. Marquardt et al.
JOURNAL OF HEPATOLOGY (2012)
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells
Guillaume Boiteux et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
EGFR and VEGFR as potential target for biological therapies in HCC cells
Gianlulgi Giannelli et al.
CANCER LETTERS (2008)
Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation
C. Wolfrum
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers
Yan Wang et al.
CANCER RESEARCH (2007)
Detection of transcript for brain-type fatty acid-binding protein in tumor and urine of patients with renal cell carcinoma
Takumi Teratani et al.
UROLOGY (2007)